Cart
sales@molnova.com
25,28-Di-epi-cyasterone
CAS No. 54082-42-7
25,28-Di-epi-cyasterone( ——— )
Catalog No. M38521 CAS No. 54082-42-7
Isocyasterone is an insect metamorphosing substance, which can be isolated from Cyathula capitata.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name25,28-Di-epi-cyasterone
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsocyasterone is an insect metamorphosing substance, which can be isolated from Cyathula capitata.
-
DescriptionIsocyasterone is an insect metamorphosing substance, which can be isolated from Cyathula capitata.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number54082-42-7
-
Formula Weight520.65
-
Molecular FormulaC29H44O8
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hikino H, et al., Isocyasterone, an insect metamorphosing substance from Cyathula capitataJ. Phytochemistry, 1971, 10(12): 3173-3178.
molnova catalog
related products
-
PF-05231023
PF-05231023 is a long-acting fibroblast growth factor 21 (FGF21) analog and is an FGF21-receptor agonist. It is also suitable for development as a potential treatment for T2DM. PF-05231023 is a analog of long-acting fibroblast growth factor 21.
-
DENV-IN-5
Denv-in-5 is an effective and selective dengue virus (DENV) inhibitor with EC50 values of 1.47, 9.23, 7.08, 8.91 μM for denV-I-IV and 0.1512 μM for HIV-1IIIB.
-
Soyasaponin Bb
Soyasaponin Bb can suppress Eca-976 cell growth, reverse effects on over expression of c-met, VEGF, and induce cell apoptosis through inhibiting HDAC1-NF-kappaB and activating PETEN and caspase-3 signaling pathways.
